Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation

Current Opinion in Pharmacology
C A Dinarello

Abstract

All biological agents currently used for reducing TNFalpha activity in disease are neutralization strategies; however, there are several strategies for reducing interleukin (IL)-1 activities: the IL-1 receptor antagonist (IL-1Ra), anti-IL-1beta monoclonal antibodies, the IL-1 Trap, IL-1 receptor type I antibodies, antibodies to the IL-1 receptor accessory chain and inhibitors of IL-1beta-converting enzyme, now termed caspase-1. In fact, caspase-1 inhibitors are the first orally active agents that target cytokines, as these inhibitors prevent the processing and release of active forms for IL-1beta and IL-18, which is a member of the IL-1 family. The IL-1 Trap is a new concept in using soluble forms of cytokine receptors to bind and neutralize a specific cytokine. The Trap takes advantage of the high affinity of the two signaling chains of the cell surface IL-1 receptor linked by the Fc portion of IgG1. The IL-1Ra is currently approved to treat rheumatoid arthritis; in over 75 000 patients, the IL-1Ra has provided insights into the role of IL-1 in local and systemic inflammation, as well as the safety of long-term reduction of IL-1 activity.

Citations

Oct 24, 2007·The Journal of Hand Surgery, European Volume·M BerglundM Wiig
Apr 2, 2011·The Journal of Biological Chemistry·Jaewoo HongSoohyun Kim
Mar 24, 2009·Annual Review of Immunology·Charles A Dinarello
Feb 3, 2007·The Journal of Clinical Investigation·Kevin J Tracey
Jan 8, 2008·Arthritis Research & Therapy·Raimund W KinneGerd-R Burmester
Feb 15, 2013·PloS One·Muhammad Sajid Hamid AkashShuqing Chen
Jun 6, 2012·Journal of Applied Oral Science : Revista FOB·João Antonio Chaves de SouzaJoni Augusto Cirelli
Apr 5, 2011·Biomarker Insights·Udensi K UdensiRaphael D Isokpehi
Apr 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Claudio MastronardiMa-Li Wong
Jan 8, 2010·Cardiovascular Research·Olga BarreiroFrancisco Sánchez-Madrid
Oct 2, 2008·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Francesca GotschSonia S Hassan
Mar 28, 2008·Expert Opinion on Investigational Drugs·Csaba P Kovesdy, Kamyar Kalantar-Zadeh
Nov 8, 2008·Expert Opinion on Biological Therapy·Mihai G NeteaLeo A B Joosten
Jan 25, 2012·Journal of Pharmaceutical Sciences·Muhammad Sajid Hamid AkashShuqing Chen
Sep 16, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Andrew C IssekutzHeather F Macmillan
Apr 28, 2010·Journal of Neuroimmunology·Elizabeth FoxRaphaela Goldbach-Mansky
Oct 27, 2009·Best Practice & Research. Clinical Rheumatology·Sebastiaan J VastertAlexei A Grom
Apr 30, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Juan Pablo de Rivero VaccariRobert W Keane
Jan 27, 2009·Brain Research Reviews·Ke Ren, Richard Torres
Feb 7, 2008·Journal of Immunological Methods·Ki-Hong KimDo-Young Yoon
Sep 25, 2007·International Journal of Medical Microbiology : IJMM·Peyman KelkAnders Johansson
Apr 3, 2007·Immunology Letters·Ligia I CraciunEtienne Dupont
Aug 7, 2007·Experimental Physiology·Julio LicinioMa-Li Wong
Sep 1, 2005·Journal of Clinical Periodontology·Giovanni E Salvi, Niklaus P Lang
Mar 11, 2011·Journal of Biochemical and Molecular Toxicology·James V RogersJohn S Graham
Mar 21, 2006·Best Practice & Research. Clinical Rheumatology·Carol A Wallace
Mar 1, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·David M DohanBruno Gogly
Feb 14, 2006·Current Problems in Pediatric and Adolescent Health Care·Murray Passo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

The Journal of Experimental Medicine
C A Dinarello
The New England Journal of Medicine
Claus M LarsenM Y Donath
Developmental and Comparative Immunology
Sumathi SubramaniamCharles Cunningham
© 2022 Meta ULC. All rights reserved